ARQT logo

Arcutis Biotherapeutics, Inc. (ARQT) Cash From Investing

Annual CFI:

$28.82M-$151.41M(-84.01%)
December 31, 2024

Summary

  • As of today, ARQT annual cash from investing is $28.82 million, with the most recent change of -$151.41 million (-84.01%) on December 31, 2024.
  • During the last 3 years, ARQT annual cash from investing has risen by +$104.77 million (+137.94%).
  • ARQT annual cash from investing is now -84.01% below its all-time high of $180.23 million, reached on December 31, 2023.

Performance

ARQT Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

Quarterly CFI:

-$25.25M-$42.67M(-244.91%)
September 30, 2025

Summary

  • As of today, ARQT quarterly cash from investing is -$25.25 million, with the most recent change of -$42.67 million (-244.91%) on September 30, 2025.
  • Over the past year, ARQT quarterly cash from investing has dropped by -$110.02 million (-129.78%).
  • ARQT quarterly cash from investing is now -123.43% below its all-time high of $107.75 million, reached on March 31, 2023.

Performance

ARQT Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

TTM CFI:

$38.80M-$110.02M(-73.93%)
September 30, 2025

Summary

  • As of today, ARQT TTM cash from investing is $38.80 million, with the most recent change of -$110.02 million (-73.93%) on September 30, 2025.
  • Over the past year, ARQT TTM cash from investing has increased by +$107.05 million (+156.86%).
  • ARQT TTM cash from investing is now -86.37% below its all-time high of $284.62 million, reached on September 30, 2023.

Performance

ARQT TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARQTcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ARQT Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-84.0%-129.8%+156.9%
3Y3 Years+137.9%+87.2%+136.6%
5Y5 Years+209.5%+72.5%+127.3%

ARQT Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-84.0%+133.1%-123.4%+87.2%-86.4%+136.1%
5Y5-Year-84.0%+115.8%-123.4%+87.2%-86.4%+114.3%
All-TimeAll-Time-84.0%+115.8%-123.4%+87.2%-86.4%+114.3%

ARQT Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$25.25M(-244.9%)
$38.80M(-73.9%)
Jun 2025
-
$17.42M(+48.3%)
$148.83M(+114.9%)
Mar 2025
-
$11.75M(-66.3%)
$69.27M(+140.3%)
Dec 2024
$28.82M(-84.0%)
$34.88M(-58.9%)
$28.82M(+142.2%)
Sep 2024
-
$84.78M(+236.4%)
-$68.24M(+36.5%)
Jun 2024
-
-$62.14M(-116.5%)
-$107.47M(-345.5%)
Mar 2024
-
-$28.70M(+53.9%)
$43.78M(-75.7%)
Dec 2023
$180.23M(+306.7%)
-$62.19M(-236.5%)
$180.23M(-36.7%)
Sep 2023
-
$45.55M(-48.9%)
$284.62M(+580.8%)
Jun 2023
-
$89.12M(-17.3%)
$41.81M(+695.6%)
Mar 2023
-
$107.75M(+155.3%)
$5.25M(+106.0%)
Dec 2022
-$87.20M
$42.20M(+121.4%)
-$87.20M(+17.7%)
Sep 2022
-
-$197.26M(-475.3%)
-$105.90M(-211.7%)
Jun 2022
-
$52.56M(+243.6%)
$94.83M(+177.3%)
DateAnnualQuarterlyTTM
Mar 2022
-
$15.30M(-34.9%)
-$122.65M(-61.5%)
Dec 2021
-$75.95M(+58.2%)
$23.50M(+577.0%)
-$75.95M(+56.7%)
Sep 2021
-
$3.47M(+102.1%)
-$175.34M(+35.2%)
Jun 2021
-
-$164.92M(-366.0%)
-$270.53M(-171.9%)
Mar 2021
-
$62.00M(+181.7%)
-$99.50M(+45.3%)
Dec 2020
-$181.82M(-590.7%)
-$75.89M(+17.2%)
-$181.82M(-28.1%)
Sep 2020
-
-$91.71M(-1602.2%)
-$141.93M(-388.8%)
Jun 2020
-
$6.11M(+130.0%)
-$29.04M(+22.3%)
Mar 2020
-
-$20.33M(+43.5%)
-$37.38M(-42.0%)
Dec 2019
-$26.32M(-128.3%)
-$36.00M(-269.9%)
-$26.32M(-1316.8%)
Sep 2019
-
$21.18M(+1045.3%)
-$1.86M(+91.9%)
Jun 2019
-
-$2.24M(+75.8%)
-$23.04M(-10.8%)
Mar 2019
-
-$9.27M(+19.6%)
-$20.80M(-80.4%)
Dec 2018
-$11.53M(>-9900.0%)
-$11.53M
-$11.53M
Dec 2017
$0.00
-
-

FAQ

  • What is Arcutis Biotherapeutics, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. annual cash from investing year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. quarterly cash from investing year-on-year change?
  • What is Arcutis Biotherapeutics, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Arcutis Biotherapeutics, Inc.?
  • What is Arcutis Biotherapeutics, Inc. TTM cash from investing year-on-year change?

What is Arcutis Biotherapeutics, Inc. annual cash from investing?

The current annual cash from investing of ARQT is $28.82M

What is the all-time high annual cash from investing for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high annual cash from investing is $180.23M

What is Arcutis Biotherapeutics, Inc. annual cash from investing year-on-year change?

Over the past year, ARQT annual cash from investing has changed by -$151.41M (-84.01%)

What is Arcutis Biotherapeutics, Inc. quarterly cash from investing?

The current quarterly cash from investing of ARQT is -$25.25M

What is the all-time high quarterly cash from investing for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high quarterly cash from investing is $107.75M

What is Arcutis Biotherapeutics, Inc. quarterly cash from investing year-on-year change?

Over the past year, ARQT quarterly cash from investing has changed by -$110.02M (-129.78%)

What is Arcutis Biotherapeutics, Inc. TTM cash from investing?

The current TTM cash from investing of ARQT is $38.80M

What is the all-time high TTM cash from investing for Arcutis Biotherapeutics, Inc.?

Arcutis Biotherapeutics, Inc. all-time high TTM cash from investing is $284.62M

What is Arcutis Biotherapeutics, Inc. TTM cash from investing year-on-year change?

Over the past year, ARQT TTM cash from investing has changed by +$107.05M (+156.86%)
On this page